| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 05/26/2005 | US20050113338 Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
| 05/26/2005 | US20050113299 Protein a compositions and methods of use |
| 05/26/2005 | US20050112574 Isolated nucleic acid; angiogenesis inhibitor |
| 05/26/2005 | US20050112565 Proteases |
| 05/26/2005 | US20050112175 Drug delivery device |
| 05/26/2005 | US20050112126 Anti-VEGF antibodies |
| 05/26/2005 | US20050112062 Anti-idiotypic vascular endothelial growth factor antibodies and their use as medicaments |
| 05/25/2005 | EP1533313A1 Novel derivative of flavone c-glycoside and composition containing the same |
| 05/25/2005 | EP1533294A1 Beta-alanine derivative and use thereof |
| 05/25/2005 | EP1532981A1 Stable eye drops containing latanoprost as the active ingredient |
| 05/25/2005 | EP1532242A2 Methods for preparing purified prostaglandin e synthase |
| 05/25/2005 | EP1532145A1 Pyrazole compositions useful as inhibitors of gsk-3 |
| 05/25/2005 | EP1532122A1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 05/25/2005 | EP1531906A1 Novel screens to identify agents that modulate retinal blood vessel function and pericyte function and diagnostic and therapeutic application therefor |
| 05/25/2005 | EP1531847A2 Pharmaceutical formulation |
| 05/25/2005 | EP1531812A1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthristis |
| 05/25/2005 | EP1531793A1 Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent |
| 05/25/2005 | EP1341791B1 Thioether substituted imidazoquinolines |
| 05/25/2005 | EP1165058B1 Azalide antibiotics for the topical treatment or prevention of ocular infections |
| 05/25/2005 | CN1620510A Cytokine protein family |
| 05/25/2005 | CN1620467A Secreted protein |
| 05/25/2005 | CN1620461A 2-amino-propanol derivatives |
| 05/25/2005 | CN1620458A 噻吩并嘧啶 Thienopyrimidine |
| 05/25/2005 | CN1620451A Benzhydryl derivatives |
| 05/25/2005 | CN1620433A Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme |
| 05/25/2005 | CN1620424A Compounds for the treatment of inflammatory disorders |
| 05/25/2005 | CN1620414A 维生素d类似物 Vitamin d analogues |
| 05/25/2005 | CN1620325A Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
| 05/25/2005 | CN1620304A Prevention and treatment of oxidative stress disorders by glutathione and phase IIdetoxification enzymes |
| 05/25/2005 | CN1620297A 止痒剂 Antipruritic |
| 05/25/2005 | CN1620294A Pyrimidine A2b selective antagonist compounds, their synthesis and use |
| 05/25/2005 | CN1620288A Pharmaceutical use of COX-2 inhibitors in angiogenesis-mediated ocular disorders |
| 05/25/2005 | CN1203072C Pyranoindoles for treating alaucoma |
| 05/25/2005 | CN1203058C Piperidine derivatives and drugs containing these derivatives as active ingredient |
| 05/25/2005 | CN1202855C Traditional Chinese medicine for deafness and tinnitus and its preparation method |
| 05/25/2005 | CN1202819C Intraocular pressure reducing agent |
| 05/24/2005 | US6897319 Therapeutic drugs for treating central nervous system disorders |
| 05/24/2005 | US6897318 Process for making substituted pyrazoles |
| 05/24/2005 | US6897231 Jun n- terminal kinase inhibitors such as 3-(4-methoxyphenyl)-1H-indazole |
| 05/24/2005 | US6897226 NK-1 receptor active amine oxide prodrugs |
| 05/24/2005 | US6897221 Urea substituted imidazoquinolines |
| 05/24/2005 | US6897211 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors |
| 05/24/2005 | US6897210 Anticancer agents; antiarthritic agents |
| 05/24/2005 | US6897207 Kinase inhibitors; angiogenesis inhibitors, anticancer agents, antiinflammatory agents and chronic obstructive pulmonary disease inhibitors |
| 05/24/2005 | US6897203 Polysaccharidic esters of retinoic acid |
| 05/24/2005 | US6897201 Administering a nucleoside 5'-pyrophosphate pyranoside or analogue, of given formula |
| 05/24/2005 | CA2138960C Ophthalmic compositions and methods for preserving and using same |
| 05/19/2005 | WO2005014576A8 Isoquinolinone derivative, process for producing the same and use thereof |
| 05/19/2005 | US20050107458 used as diagnostic kits, bioassay and/or drugs for preventing cancers, Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, stroke, ischaemia, Huntington's disease, epilepsy, multiple sclerosis, neuropathy, or injuries of the brain or spinal chord, or as tyrosine kinase inhibitors |
| 05/19/2005 | US20050107457 Indazole derivatives as JNK inhibitors and compositions and methods related thereto |
| 05/19/2005 | US20050107436 Compounds for inflammation and immune-related uses |
| 05/19/2005 | US20050107432 such as 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-ylidene]methylpiperidine, used for treating nervous system, neurodegenerative and/or psychological disorders |
| 05/19/2005 | US20050107429 Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
| 05/19/2005 | US20050107428 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; anticholesterol agents; cardiovascular disorders |
| 05/19/2005 | US20050107406 Angiogenesis inhibitors |
| 05/19/2005 | US20050107397 Sulfonamide derivatives as d3-receptor agonists |
| 05/19/2005 | US20050107390 i.e. 7-[(3R)-3-Amino-4-(3,4-difluorophenyl)butanoyl]-3-methyl-6-(phenylmethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazine, dihydrochloride; antilipemic, antiobesity |
| 05/19/2005 | US20050107384 to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a HDAC in a biological sample comprising detecting or measuring the formation of a complex between a labelled compound as defined in claim (I) and a HDAC |
| 05/19/2005 | US20050107345 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 05/19/2005 | US20050107331 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 05/19/2005 | US20050107291 Compositions and methods for treating or preventing diseases of body passageways |
| 05/19/2005 | US20050106679 Leptin proteins |
| 05/19/2005 | US20050106272 Co-beadlet of dha and rosemary and methods of use |
| 05/19/2005 | US20050106271 containing a clove perfume and a peppermint perfume; suppressing peculiar chemical smells |
| 05/19/2005 | US20050106265 Preservative method |
| 05/19/2005 | US20050106189 Pharmaceutical formulation comprising cyclosporin and use thereof |
| 05/19/2005 | US20050106099 Fusion proteins |
| 05/18/2005 | EP1530573A1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 05/18/2005 | EP1530567A1 Pyridinyl substituted (1,2,3,)triazoles as inhibitors of the tgf-beta signalling pathway |
| 05/18/2005 | EP1530565A1 Substituted thiophene carboxamide compounds for the treatment of inflammation |
| 05/18/2005 | EP1530483A2 T cell receptor cdr3 sequences and methods for detection |
| 05/18/2005 | EP1265860B1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 05/18/2005 | EP1263724B1 Novel compounds |
| 05/18/2005 | EP1224195B1 C-aryl glucoside sglt2 inhibitors |
| 05/18/2005 | EP1186302B1 Ocular tension lowering composition for topical adminstration |
| 05/18/2005 | CN1617868A Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
| 05/18/2005 | CN1617865A Phenylalkynes |
| 05/18/2005 | CN1617862A Novel 1, 2, 4-thiadiazole derivatives as melanocortin receptor modulators |
| 05/18/2005 | CN1617859A 5-sulfanyl-4h-1, 2, 4-triazole derivatives and their use as a medicament |
| 05/18/2005 | CN1617743A New pharmaceutical combinations for nos inhibitors |
| 05/18/2005 | CN1617736A Vaccine and method for treatment of motor neurone diseases |
| 05/18/2005 | CN1616452A 维生素d类似物 Vitamin d analogues |
| 05/18/2005 | CN1616422A Disulfide derivatives useful for treating allergic diseases |
| 05/18/2005 | CN1616088A Interferon oculentum |
| 05/18/2005 | CN1616084A Botulinum toxin pharmaceutical compositions |
| 05/18/2005 | CN1615902A Ribavirin eye gel eye medicine and its producing process |
| 05/18/2005 | CN1615880A Combined agents for treatment of glaucoma |
| 05/18/2005 | CN1615879A Combined agents for treatment of glaucoma |
| 05/18/2005 | CN1615873A Azaindoles compound |
| 05/18/2005 | CN1202103C Preparation method of red sageroot total phenolic acid |
| 05/18/2005 | CN1202101C Medicinal compound with anti-infection, anti-inflammatory and antipyretic, and improving immunity function |
| 05/18/2005 | CN1202093C Substituted heterocyclic compound |
| 05/18/2005 | CN1202068C Aspirin-triggered lipid mediators |
| 05/18/2005 | CN1201818C Vaccine |
| 05/18/2005 | CN1201812C Pharmaceutical preparation containing cyclopeptide and chemotherapeutic agent or angiogenesis inhibitor |
| 05/18/2005 | CN1201811C Chinese medicine composition for treating myopia and preparing method thereof |
| 05/18/2005 | CN1201768C Medication for treating diabetic retinopathy and its preparing method |
| 05/18/2005 | CN1201750C Oculentum for treating eye disease and preparing method thereof |
| 05/18/2005 | CN1201734C Use of sulfocanbamide derivative in preparation of medicine treating eye yellow spot variation |
| 05/17/2005 | US6894067 5-heteroatom-substituted pyrazoles |